Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Moss

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 27, 2011
False-positive screening results in the European randomized study of screening for prostate cancerTuomas P Kilpeläinen, Teuvo L J Tammela, Monique Roobol, et al.
BJU International|April 23, 2016
Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC)Leonard P Bokhorst, Marco Zappa, Sigrid V Carlsson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trialHenry C Kitchener, Clare Gilham, Alexandra Sargent, et al.
Archives of Medical Research|March 12, 2002
The positive experience of screening quality among users of a cervical cancer detection centerEduardo César Lazcano-Ponce, Sue Moss, Aurelio Cruz-Valdez, et al.
European Urology|April 1, 2019
Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?Sigrid V Carlsson, Marianne Månsson, Sue Moss, et al.
Health Technology Assessment (Winchester, England)|November 3, 2020
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCTStephen Duffy, Daniel Vulkan, Howard Cuckle, et al.
The Lancet. Oncology|December 15, 2010
Automation-assisted versus manual reading of cervical cytology (MAVARIC): a randomised controlled trialHenry C Kitchener, Roger Blanks, Graham Dunn, et al.
British Journal of Cancer|November 18, 2016
Impact of cause of death adjudication on the results of the European prostate cancer screening trialStephen D Walter, Harry J de Koning, Jonas Hugosson, et al.
Cancer Research|August 15, 2009
Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factorsKate Walker, Olivia Fletcher, Nichola Johnson, et al.
The Lancet. Oncology|June 23, 2009
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trialHenry C Kitchener, Maribel Almonte, Claire Thomson, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|July 27, 2011
False-positive screening results in the European randomized study of screening for prostate cancerTuomas P Kilpeläinen, Teuvo L J Tammela, Monique Roobol, et al.
BJU International|April 23, 2016
Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC)Leonard P Bokhorst, Marco Zappa, Sigrid V Carlsson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trialHenry C Kitchener, Clare Gilham, Alexandra Sargent, et al.
Archives of Medical Research|March 12, 2002
The positive experience of screening quality among users of a cervical cancer detection centerEduardo César Lazcano-Ponce, Sue Moss, Aurelio Cruz-Valdez, et al.
European Urology|April 1, 2019
Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?Sigrid V Carlsson, Marianne Månsson, Sue Moss, et al.
Health Technology Assessment (Winchester, England)|November 3, 2020
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCTStephen Duffy, Daniel Vulkan, Howard Cuckle, et al.
The Lancet. Oncology|December 15, 2010
Automation-assisted versus manual reading of cervical cytology (MAVARIC): a randomised controlled trialHenry C Kitchener, Roger Blanks, Graham Dunn, et al.
British Journal of Cancer|November 18, 2016
Impact of cause of death adjudication on the results of the European prostate cancer screening trialStephen D Walter, Harry J de Koning, Jonas Hugosson, et al.
Cancer Research|August 15, 2009
Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factorsKate Walker, Olivia Fletcher, Nichola Johnson, et al.
The Lancet. Oncology|June 23, 2009
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trialHenry C Kitchener, Maribel Almonte, Claire Thomson, et al.
Pageof 6